Raras
Buscar doenças, sintomas, genes...
Displasia osteofibrótica
ORPHA:488265CID-10 · M85.0OMIM 607278DOENÇA RARA

É uma lesão fibro-óssea benigna (não cancerosa) que afeta o osso de bebês e crianças, e que geralmente desaparece sozinha. Ela costuma surgir na camada mais externa (córtex) da parte da frente do meio do ososso da canela (tíbia). Os pacientes geralmente apresentam inchaço ou uma curvatura indolor na tíbia. Em alguns casos, foi relatada a evolução para um tipo de tumor chamado adamantinoma.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É uma lesão fibro-óssea benigna (não cancerosa) que afeta o osso de bebês e crianças, e que geralmente desaparece sozinha. Ela costuma surgir na camada mais externa (córtex) da parte da frente do meio do ososso da canela (tíbia). Os pacientes geralmente apresentam inchaço ou uma curvatura indolor na tíbia. Em alguns casos, foi relatada a evolução para um tipo de tumor chamado adamantinoma.

Publicações científicas
255 artigos
Último publicado: 2026 May
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: M85.0
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Características mais comuns

100%prev.
Fratura patológica
Frequência: 6/6
17%prev.
Hipoplasia da fíbula
Ocasional (29-5%)
17%prev.
Pectus excavatum
Ocasional (29-5%)
Pseudoartrose
Herança autossômica dominante
HP:0003577
6sintomas
Muito frequente (1)
Ocasional (2)
Sem dados (3)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 6 características clínicas mais associadas, ordenadas por frequência.

Fratura patológicaPathologic fracture
Frequência: 6/6100%
Hipoplasia da fíbulaFibular hypoplasia
Ocasional (29-5%)17%
Pectus excavatum
Ocasional (29-5%)17%
PseudoartrosePseudoarthrosis
Herança autossômica dominanteAutosomal dominant inheritance

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico255PubMed
Últimos 10 anos102publicações
Pico202013 papers
Linha do tempo
2026Hoje · 2026🧪 2019Primeiro ensaio clínico📈 2020Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição.

Autosomal dominant
METHepatocyte growth factor receptorDisease-causing germline mutation(s) (gain of function) inAltamente restrito
FUNÇÃO

Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand. Regulates many physiological processes including proliferation, scattering, morphogenesis and survival. Ligand binding at the cell surface induces autophosphorylation of MET on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1,

LOCALIZAÇÃO

MembraneSecreted

VIAS BIOLÓGICAS (7)
MET Receptor ActivationDrug-mediated inhibition of MET activationSema4D mediated inhibition of cell attachment and migrationNegative regulation of MET activityMECP2 regulates neuronal receptors and channels
EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
21.3 TPM
Fibroblastos
18.5 TPM
Tireoide
16.7 TPM
Adipose Visceral Omentum
16.2 TPM
Mama
15.4 TPM
OUTRAS DOENÇAS (8)
hepatocellular carcinomahereditary papillary renal cell carcinomaarthrogryposis, distal, IIa 11autosomal recessive nonsyndromic hearing loss 97
HGNC:7029UniProt:P08581

Variantes genéticas (ClinVar)

418 variantes patogênicas registradas no ClinVar.

🧬 MET: NM_000245.4(MET):c.3391A>T (p.Met1131Leu) ()
🧬 MET: NM_000245.4(MET):c.1058C>A (p.Ser353Tyr) ()
🧬 MET: NM_000245.4(MET):c.3786C>G (p.Thr1262=) ()
🧬 MET: NM_000245.4(MET):c.2581A>G (p.Lys861Glu) ()
🧬 MET: NM_000245.4(MET):c.3908T>C (p.Leu1303Pro) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 83 variantes classificadas pelo ClinVar.

21
62
Patogênica (25.3%)
VUS (74.7%)
VARIANTES MAIS SIGNIFICATIVAS
MET: NM_000245.4(MET):c.617T>C (p.Phe206Ser) [Conflicting classifications of pathogenicity]
MET: NM_000245.4(MET):c.3403A>T (p.Ser1135Cys) [Conflicting classifications of pathogenicity]
MET: NM_000245.4(MET):c.3842C>G (p.Ala1281Gly) [Conflicting classifications of pathogenicity]
MET: NM_000245.4(MET):c.4122C>A (p.Asn1374Lys) [Conflicting classifications of pathogenicity]
MET: NM_000245.4(MET):c.1450C>T (p.His484Tyr) [Conflicting classifications of pathogenicity]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Displasia osteofibrótica

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

1 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥉Melhor nível de evidência: Relato de caso
Timeline de publicações
100 papers (10 anos)
#1

A case of solitary bone plasmacytoma to multiple myeloma: a case report.

Frontiers in medicine2026

Solitary bone plasmacytoma of the rib is uncommon but recognized. We report a case presenting with recurrent, predominantly nocturnal chest wall pain. Imaging revealed an expansile lesion on the left ninth rib and initially suggested fibrous/osteofibrous dysplasia. The patient underwent resection of the involved rib segment. Histopathology and immunohistochemistry confirmed solitary bone plasmacytoma. The patient declined the recommended adjuvant radiotherapy. Twenty-one months later, the disease progressed to multiple myeloma.

#2

MEK inhibitor Mirdametinib promotes fracture healing in osteofibrous dysplasia RASopathy.

The Journal of clinical investigation2026 Feb 26

Osteofibrous dysplasia (OFD) is a skeletal RASopathy presenting with periosteal bone lesions that may progress to fracture and delayed healing (pseudarthrosis). MET gene mutations reducing ubiquitin-mediated protein degradation via loss of the juxtamembrane domain (METΔJMD) were previously identified in OFD patients, resulting in ligand-dependent gain-of-function. The impact of METΔJMD expression on skeletal progenitor cell differentiation and the potential efficacy of targeted therapies remain unclear. We engineered MetΔJMD mice and showed that MetΔJMD expression inhibited osteogenic differentiation of skeletal progenitor cells in vitro and impaired cortical bone development and reduced bone stiffness in vivo. In contrast, conditional deletion of Met enhanced osteogenic differentiation of periosteal progenitor cells. Inhibition of MAPK signaling with MEK inhibitors restored osteogenic differentiation of mouse MetΔJMD skeletal progenitor cells and promoted activation of transcriptional signatures associated with skeletal development and osteoblast differentiation in OFD patient pseudarthrosis-derived primary cells. With this preclinical support, we treated with the MEK inhibitor mirdametinib a pediatric OFD patient suffering from a 3-year history of persistent pseudarthrosis, resulting in fracture union. Our findings demonstrate a bi-directional role for MET in regulating osteogenic differentiation of skeletal progenitor cells and a therapeutic avenue to improve clinical outcomes for this, and potential other, skeletal RASopathies. .

#3

Clinicopathological analysis of osteofibrous dysplasia and adamantinoma: A single institution experience.

Annals of diagnostic pathology2026 Jun

Osteofibrous dysplasia (OFD) and adamantinoma are rare primary bone tumors. The present study is a clinico-pathological analysis of OFDs and adamantinomas, highlighting the value of distinguishing these tumors from their mimics and evaluating their proximity. OFDs, adamantinomas, fibrous dysplasias (FDs), and intraosseous synovial sarcomas (SS) of the tibia and fibula, diagnosed from 2012 to 2024 (12 years) were retrieved. Fifty-eight tumors were reviewed, and finally, 19 OFDs and 28 adamantinomas were analyzed. After a review, the diagnosis was modified in 12/58 (20.7%) tumors; with 4 OFDs revised to FDs; 2 FDs to OFDs; 2 intra-osseous SSs to classic adamantinomas; 3 OFD-like adamantinomas to classic adamantinomas, and a single de-differentiated adamantinoma to classic adamantinoma. The median age for OFD (10 years) was lower than that of adamantinoma (25 years). The radiological impression concurred with the histopathological diagnosis in 40% of OFDs and 60% of adamantinomas. Among 28 adamantinomas, there was a single OFD-like adamantinoma, 25 classic adamantinomas, and 2 dedifferentiated adamantinomas. Pan keratin (AE1/AE3) was positive in 18/19 (94.7%) OFDs and 19/20 (95%) adamantinomas. P40 (5/5, 100%) and p63 (6/8, 75%) were useful in the diagnosis of adamantinoma. Most adamantinomas were treated with surgery. None of the OFDs progressed to an adamantinoma during a median follow-up of 51.15 months(range = 4.36 to 97.94 months). Five out of 28 (17.9%) patients with an adamantinoma developed recurrences and 5 (17.9) developed metastases. The most commonly associated patterns with recurrences and metastasis in a classic adamantinoma were spindle and basaloid. The present study constitutes the first and the largest series of OFDs and adamantinomas from our subcontinent. OFD, OFD-like adamantinoma and adamantinoma may display overlapping clinico-radio-pathological profiles, and as such are potentially associated with diagnostic errors. Although there is a morphological continuum between OFD and adamantinoma, we did not observe a disease progression during the limited follow-up. It is crucial to distinguish an OFD and an adamantinoma from their various mimics, given treatment-associated implications. A long-term follow-up is suggested, as recurrences and metastases can occur late during the disease course.

#4

A rare case of supinator syndrome caused by osteofibrous dysplasia of the radius.

JPRAS open2026 Mar

We report the case of a 57-year-old male who presented to our emergency room due to progressive paresis of the muscles innervated by the deep branch of the radial nerve in the right forearm. The patient suffered from osteofibrous dysplasia and an x-ray revealed the polyostotic disease had also affected his radius. High resolution ultrasound revealed that an exostosis of the radius had caused compression of the posterior interosseous nerve unusually distally in the supinator tunnel. The patient underwent nerve decompression and recovered full strength in his wrist-, and finger extensors approximately 9 months postoperatively. This case report illustrates a case of a rare disease, i.e. osteofibrous dysplasia of the radius, in conjunction with the first published report of an unusually located nerve compression syndrome, i.e. supinator syndrome, caused by this very disease.

#5

Proximal Ulna Adamantinoma.

Journal of hand surgery global online2026 Jan

Adamantinoma is a rare, malignant tumor that is typically seen in the tibia but has been reported in all long bones. We present the case of a woman who presented as a teenager with a pathologic fracture of the proximal ulna that was initially diagnosed as osteofibrous dysplasia and treated with internal fixation. After the lesion was identified in adulthood as adamantinoma, she was converted to a one-bone forearm procedure as a salvage treatment.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC154 artigos no totalmostrando 100

2026

A case of solitary bone plasmacytoma to multiple myeloma: a case report.

Frontiers in medicine
2026

MEK inhibitor Mirdametinib promotes fracture healing in osteofibrous dysplasia RASopathy.

The Journal of clinical investigation
2026

Clinicopathological analysis of osteofibrous dysplasia and adamantinoma: A single institution experience.

Annals of diagnostic pathology
2025

Motorized Intramedullary Bone Transport Nail for Reconstruction of a Large Diaphyseal Bone Defect after Tumor Resection in a Child-A Case Report.

Children (Basel, Switzerland)
2026

A rare case of supinator syndrome caused by osteofibrous dysplasia of the radius.

JPRAS open
2026

Proximal Ulna Adamantinoma.

Journal of hand surgery global online
2025

Osteofibrous Dysplasia Involving Both Tibia and Fibula: A Rare Campanacci‑Type Presentation.

Journal of the Belgian Society of Radiology
2025

Histological Dedifferentiation in Recurrent Adamantinoma of the Tibia: A Case Report.

Journal of orthopaedic case reports
2025

Osteofibrous dysplasia, osteofibrous Dysplasia-Like adamantinoma, and adamantinoma: A Single-center retrospective analysis.

Journal of bone oncology
2025

Multiple osteofibrous dysplasia combined with femoral fracture with proximal femur shepherd's crook and femoral pseudojoint formation: case report and literature review.

Frontiers in surgery
2026

Osteofibrous dysplasia (OFD) and adamantinoma: A comprehensive review and updates.

Histology and histopathology
2025

SATB2 immunohistochemistry in osteosarcoma: Utility in diagnosis and differentiation from histologic mimics.

Indian journal of pathology & microbiology
2025

Pediatric Limb Reconstruction Gone Wrong: Risks of Pursuing Treatment Without Thorough Psychological Evaluation.

Journal of the Pediatric Orthopaedic Society of North America
2025

Bilateral Total Hip Arthroplasty for Osteofibrous Dysplasia Assisted by CT-Guided 3D Printing: A Case Report.

Clinical case reports
2025

Feasibility of non-radical resection combined with internal fixation for adolescents with lower limb fibrous dysplasia: a single-center retrospective study with a small sample size.

Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology
2025

Osteofibrous dysplasia of the 8th rib: a case report.

Indian journal of thoracic and cardiovascular surgery
2024

Novel Technique for Biopsying Osteofibrous Dysplasia Using a Vacuum-assisted Bone Harvester: A Case Report.

Journal of orthopaedic case reports
2024

Fibrous Dysplasia Involving Cranio-Facial Region Treated with Zolendronic Acid: A Single Institutional Experience and Review of Literature.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
2024

A genetic mouse model mimicking MET related human osteofibrous dysplasia is characterized by delays in fracture repair and defective osteogenesis.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2025

Evaluation of subperiosteal hemicortical resection and bone grafting to treat tibial osteofibrous dysplasia in children.

Journal of pediatric orthopedics. Part B
2024

Osteofibrous Dysplasia of Humerus: An Unusual Presentation of a Rare Lesion.

Journal of hand and microsurgery
2024

Recurrent Adamantinoma With Fibrous Dysplasia-like Feature.

Clinical pathology (Thousand Oaks, Ventura County, Calif.)
2024

Congenital tibial pseudarthrosis: A challenge in pediatric radiology.

Radiology case reports
2024

Osteofibrous dysplasia: a narrative review.

Journal of orthopaedic surgery and research
2024

[Detection of MDM2 gene amplification by fluorescence in situ hybridization and its diagnostic value in low-grade osteosarcoma].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2024

Osteofibrous dysplasia of the fibula occurring in a middle-aged woman.

Asian journal of surgery
2024

Large-Scale assessment of ChatGPT's performance in benign and malignant bone tumors imaging report diagnosis and its potential for clinical applications.

Journal of bone oncology
2024

Unusual presentation of adamantinoma with synchronous involvement of entire-lengths of the tibia and fibula in an elderly man: A case report.

International journal of surgery case reports
2023

[Osteofibrous dysplasia-like adamantinoma: report of a case].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2023

Juvenile trabecular ossifying fibroma: A case of extensive lesion of the maxilla.

International journal of surgery case reports
2023

Polyostotic Fibrous Dysplasia in a Six-year-Old Boy.

Molecular imaging and radionuclide therapy
2023

Bone pathology mimicking non-accidental injury in a child - Bewildered by bones, case report and review of the literature.

International journal of surgery case reports
2023

Comparison of MRI Findings among Osteofibrous Dysplasia, Fibrous Dysplasia, and NonOssifying Fibroma of the Long Bone.

The Indian journal of radiology & imaging
2022

Osteofibrous Dysplasia of the Clavicle Managed with Intravenous Bisphosphonates: A Case Report and Review of Literature.

Journal of orthopaedic case reports
2023

A case of neonatal osteofibrous dysplasia with novel CDK12 and DDR2 mutations.

Bone reports
2022

Osteofibrous dysplasia-like adamantinoma: A case report and literature review.

Frontiers in oncology
2022

Neonatal osteofibrous dysplasia: Synchronous tibial and fibular involvement is common.

BJR case reports
2022

Adamantinoma with a Prominent Spindle Cell Component Mimicking Intraosseous Synovial Sarcoma: Clinicopathological Features of Six Tumors.

International journal of surgical pathology
2023

Secondary osteosarcoma associated with osteofibrous dysplasia: a case report.

Skeletal radiology
2023

Approach to Primary Vertebral Tumors in the Light of the 2020 Updated World Health Organization Classification of Bone Tumors.

Turkish neurosurgery
2022

Osteofibrous dysplasia-like adamantinoma of isolated fibula in a child mimicking chronic osteomyelitis with pathological fracture.

Journal of surgical case reports
2022

Osteofibrous dysplasia of the tibia : the importance of deformity in surveillance.

The bone & joint journal
2022

Osteofibrous dysplasia: A rare case in 3-day-old female.

Radiology case reports
2021

Hemi-tibia allograft and free microvascularized fibula transplant reconstitute the tibia shaft with side to side healing: 7 year follow up of a 14-year-old boy with adamantinoma.

Case reports in plastic surgery & hand surgery
2021

Osteofibrous Dysplasia and Adamantinoma.

Surgical pathology clinics
2021

A simple management of massive bone defect after en-bloc resection of osteofibrous dysplasia of tibial shaft: A case report.

International journal of surgery case reports
2021

[Osteofibrous dysplasia-like adamantinoma of bone: a clinicopathological study of five cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2021

Osteofibrous dysplasia and adamantinoma: A summary of diagnostic challenges and surgical techniques.

Surgical oncology
2021

An unusual case of adamantinoma of long bone.

Autopsy & case reports
2022

Increased uptake of 68Ga-DOTA-FAPI-04 in bones and joints: metastases and beyond.

European journal of nuclear medicine and molecular imaging
2021

Quantitative bone SPECT/CT applications for primary bone neoplasms.

Hellenic journal of nuclear medicine
2023

Does the management of osteofibrous dysplasia of the tibia and fibula in children should be tailored to the extent and location of the lesion? A case control study investigating different surgical options.

Orthopaedics & traumatology, surgery & research : OTSR
2021

Osteofibrous dysplasia-like adamantinoma versus osteofibrous dysplasia in children: A case report of challenging diagnosis.

International journal of surgery case reports
2020

Bilateral Symmetric Sporadic Osteofibrous Dysplasia: an Unusual Case.

Indian journal of surgical oncology
2021

Fibrous osteodystrophy in a dromedary camel.

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
2021

Recurrent adamantinoma of the mandible.

International journal of oral and maxillofacial surgery
2020

High SENP3 Expression Promotes Cell Migration, Invasion, and Proliferation by Modulating DNA Methylation of E-Cadherin in Osteosarcoma.

Technology in cancer research & treatment
2021

What's New in Pediatric Orthopaedic Tumor Surgery.

Journal of pediatric orthopedics
2020

Surgical Outcome and Oncological Survival of Osteofibrous Dysplasia-Like and Classic Adamantinomas: An International Multicenter Study of 318 Cases.

The Journal of bone and joint surgery. American volume
2020

[Tumor-like bony lesions of the skeleton].

Der Orthopade
2020

Osteofibrous dysplasia-like adamantinoma treated via intercalary segmental resection with partial cortex preservation using pedicled vascularized fibula graft: a case report.

World journal of surgical oncology
2020

Outcome of osteofibrous dysplasia-like versus classic adamantinoma of long bones: a single-institution experience.

Journal of orthopaedic surgery and research
2020

Keratinocytic epidermal nevi associated with localized fibro-osseous lesions without hypophosphatemia.

Pediatric dermatology
2021

Fibrous dysplasia limited to an ossicle.

Auris, nasus, larynx
2020

Adamantinomatous tumors: Long-term follow-up study of 20 patients treated at a single institution.

Journal of surgical oncology
2020

Osteofibrous Dysplasia in a Cockatiel (Nymphicus hollandicus).

Journal of avian medicine and surgery
2020

Surgical Outcomes, Complications, and Long-Term Functionality for Free Vascularized Fibula Grafts in the Pediatric Population: A 17-Year Experience and Systematic Review of the Literature.

Journal of reconstructive microsurgery
2020

Osteolytic lesion of the tibial shaft in a young boy.

BMJ case reports
2019

AMPH-1 As A Critical Tumor Suppressor That Inhibits Osteosarcoma Progression.

Cancer management and research
2020

Growth hormone receptor promotes osteosarcoma cell growth and metastases.

FEBS open bio
2019

Adamantinoma filling the medullary space of the tibia: A case report.

Radiology case reports
2019

Osteofibrous Dysplasia of the Tibia in Children: Outcome Without Resection.

Journal of pediatric orthopedics
2019

Comprehensive Molecular Characterization of Adamantinoma and OFD-like Adamantinoma Bone Tumors.

The American journal of surgical pathology
2018

Osteofibrous dysplasia arising in the humerus: A case report.

Rare tumors
2018

Giant monostotic osteofibrous dysplasia of the ilium: A case report and review of literature.

World journal of clinical cases
2019

Extraperiosteal segmental excision for osteofibrous dysplasia of tibia with reconstruction by liquid nitrogen-treated recycled autograft.

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
2018

Adamantinoma of bone: Long-term follow-up of 46 consecutive patients.

Journal of surgical oncology
2018

Periostin expression in neoplastic and non-neoplastic diseases of bone and joint.

Clinical sarcoma research
2018

Osteofibrous Dysplasia with Rhabdoid Elements in a 38-Year-Old Man with Spontaneous Regression Over Five Years: A Case Report.

JBJS case connector
2018

Optimal Treatment of Osteofibrous Dysplasia of the Tibia.

Journal of pediatric orthopedics
2018

Paediatric osteofibrous dysplasia-like adamantinoma with classical radiological findings.

BMJ case reports
2017

Modified technique for preservation of inferior alveolar nerve during mandibulectomy.

Head & neck
2017

Bilateral Tibial Osteofibrous Dysplasia on 18F-FDG PET/CT.

Clinical nuclear medicine
2017

[Bullous Sweet's syndrome with pulmonary involvement].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
2017

Does osteofibrous dysplasia progress to adamantinoma and how should they be treated?

The bone & joint journal
2017

Osteofibrous Dysplasia Versus Ossifying Fibroma: Semantic Confusion.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
2017

Management of Large Maxillomandibular Osteofibrous Dysplasia as Part of a Humanitarian Mission.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
2016

Long-term outcome following treatment of Adamantinoma and Osteofibrous dysplasia of long bones.

Orthopaedics & traumatology, surgery & research : OTSR
2016

[Osteofibrous dysplasia of metacarpus: a case report].

Zhongguo gu shang = China journal of orthopaedics and traumatology
2016

Osteofibrous dysplasia of clavicle clinically mimicking chronic osteomyelitis.

The Indian journal of radiology & imaging
2016

[Tumor-like lesions of bone].

Der Radiologe
2016

Sclerostin expression in bone tumours and tumour-like lesions.

Histopathology
2015

Chondroblastic osteosarcoma secondary to fibrosarcoma: A case report and literature review.

Oncology letters
2015

Mutations Preventing Regulated Exon Skipping in MET Cause Osteofibrous Dysplasia.

American journal of human genetics
2015

A rare case of pure primary hemangioma of the scapula: A case report.

Oncology letters
2015

Autologous mesenchymal stem cell (MSCs) transplantation for critical-sized bone defect following a wide excision of osteofibrous dysplasia.

International journal of surgery case reports
2015

Osteofibrous Dysplasia-like Adamantinoma of the Tibia in a 15-Year-Old Girl.

American journal of orthopedics (Belle Mead, N.J.)
2015

Bone Transport for Reconstruction in Benign Bone Tumors.

Clinics in orthopedic surgery
2015

Osteofibrous dysplasia-like adamantinoma in a 3-month-old male infant: a case report.

Acta orthopaedica et traumatologica turcica
2015

Osteofibrous Dysplasia managed with Extraperiosteal excision, Autologous free fibular graft and bone graft substitute.

Journal of orthopaedic case reports
Ver todos os 154 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Displasia osteofibrótica.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Displasia osteofibrótica

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. A case of solitary bone plasmacytoma to multiple myeloma: a case report.
    Frontiers in medicine· 2026· PMID 41822898mais citado
  2. MEK inhibitor Mirdametinib promotes fracture healing in osteofibrous dysplasia RASopathy.
    The Journal of clinical investigation· 2026· PMID 41746735mais citado
  3. Clinicopathological analysis of osteofibrous dysplasia and adamantinoma: A single institution experience.
    Annals of diagnostic pathology· 2026· PMID 41653544mais citado
  4. A rare case of supinator syndrome caused by osteofibrous dysplasia of the radius.
    JPRAS open· 2026· PMID 41583415mais citado
  5. Proximal Ulna Adamantinoma.
    Journal of hand surgery global online· 2026· PMID 41439258mais citado
  6. Treatment and Management of Osteofibrous Dysplasia Like Adamantinoma - A Single Institution Experience.
    J Pediatr Soc North Am· 2026· PMID 41890885recente
  7. Motorized Intramedullary Bone Transport Nail for Reconstruction of a Large Diaphyseal Bone Defect after Tumor Resection in a Child-A Case Report.
    Children (Basel)· 2025· PMID 41597034recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:488265(Orphanet)
  2. OMIM OMIM:607278(OMIM)
  3. MONDO:0011806(MONDO)
  4. GARD:10887(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q55783494(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Displasia osteofibrótica
Compêndio · Raras BR

Displasia osteofibrótica

ORPHA:488265 · MONDO:0011806
CID-10
M85.0 · Displasia fibrosa (monostótica)
Início
Childhood, Infancy
MedGen
UMLS
C1709353
Testes
10 disponíveis
EuropePMC
Wikidata
Papers 10a
Evidência
🥉 Relato de caso
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades